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ABSTRACT 
 
Follicular carcinoma of thyroid is the second most common thyroid carcinoma accounting for 10-20 %of all thyroid 
malignancies, most commonly seen above 40 years of age. Distant metastases at the time of diagnosis is 11-20 %, 
usual presentation is asymptomatic solitary intrathyroid nodule. Its metastases is hematogenous, lung and bone are 
most commonly affected. Skull metastases is the unusual site of presentation. The present case of 60 year female 
presenting with skull , chest wall swelling, spine, lung metastases but asymptomatic thyroid lesion, is unusual. 
Keywords: Follicular carcinoma, thyroid, skull & chest wall metastases. 
Introduction 
Follicular carcinoma of thyroid is the second most 
common thyroid carcinoma after papillary carcinoma. 
It accounts for 10-20 % of all thyroid malignancies and 
is most commonly seen above 40 years of age [1]. Its 
usual presentation is asymptomatic solitary intrathyroid 
nodule. It metastasizes hematogenously, most 
commonly observed via the systemic circulation or the 
paravertebral plexus. Lymphatic spread is less common 
but is also possible. Lung and bone are most commonly 
affected. Distant metastases at the time of diagnosis are 
reported in 11-20 % of patients [2], less than 1 % is 
seen in patients < 45 years of age. There are few case 
reports of Follicular carcinoma causing unusual bony 
metastases such as skull [3], mandible [4], maxilla [5] , 
spine [6] and orbit [7]. Synchronous lung metastases in 
Follicular carcinoma have been reported in about 20 % 
of cases, with mean age of 50 years at presentation 
[8].Present case had unusual primary presentation with 
metastases in skull, chest wall, spine, lungs and no 
primary symptoms of thyroid. 
 
Case report 
 
A 60 year old female presented in OPD with swelling 
over left side of skull , left chest wall swelling and pain 
in the back.  
______________________________ 
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After clinical evaluation CT scan was advised for 
evaluating extent of bony involvement. CT scan 
showed lytic destructive lesion heterogeneously 
enhancement in right side of sacrum[ Fig 1], D 10, D 
12  vertebral body, 2
nd
 and 3 rd rib on left side with 
intrathoracic and intercostal lytic  destructive lesion 
[Fig 2], 47x35x44 mm involving clivus, pituitary fossa 
with bony expansion as well as nasopharynx, sphenoid 
sinus with extension into pre / parasellar and left 
cavernous sinus [ Fig 3]. There were subcentric 
cervical lymph nodes along with jugular chain,11 x 10 
mm left axillary lymph node, reticulo nodular opacities 
in bilateral lung parenchyma.  
 Fine needle aspiration was taken under ultrasound 
guidance from left chest wall swelling.  
The smears were air dried and stained with Giemsa 
stain which showed round cells in microacinar pattern 
and pinkish homogenous material in background [Fig 
4]. Cytomorphological diagnosis of metastatic 
Follicular carcinoma of thyroid was made in view of 
cytomorphology.Ultrasonography of neck showed 
1.5x1.5 cm calcified lesion in right lobe of 
thyroid.FNAC from thyroid nodule did not yield 
cellularity as it was calcified. Ultrasonography of 
abdomen was done which showed no metastases in 
liver or other abdominal viscera.Core needle biopsy 
from chest wall swelling was done to confirm the 
cytological diagnosis by histomorphology and Immuno 
Histochemistry. H & E stained slides of the biopsy 
showed closely packed follicles some of which 
contained colloid. Tumor cells had round to oval nuclei 
showing minimal atypia and vacuolated pale 
eosinophilic cytoplasm.[ Fig 5] Histological diagnosis 
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of metastatic Follicular carcinoma of thyroid. IHC 
markers CK, TTF-1, PAX-8, Thyroglobulin , CK 7 
showed diffuse strong positivity in tumor cells [ Fig 6-
8].Synaptophysin was negative, Ki 67 showed 01 % 
positivity. Thus a diagnosis of Metastatic Follicular 
carcinoma of thyroid was established.  
 
 
 
Fig 1:CT Scan of lytic lesion in right side sacrum Fig 2:CT Scan of left chest wall swelling,2
nd
 and 3
rd
 
rib 
 
 
 
Fig 3:CT Scan of lesion in pituitary fossa,extending 
into nasopharynx,sphenoid sinus cells  
Fig 4:Giemsa stain,40 X,Cytosmear shows 
microacinarpattern of round cells and pinkish 
background
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Fig 5:Biopsy, H &E , 40 X, acinar pattern with 
positivity in tumour cells 
        Fig 6:Thyroglobulin, 40 X, diffuse strong 
colloid                                                                         
 
 
Fig 7:CK 7 , 40 X, Diffuse strong positivity in  
tumour cells 
 
Fig 8: TTF1, 40 X, Diffuse strong positivity in 
tumor cell
Discussion 
 
Incidence of Follicular carcinoma thyroid is less than 
Papillary carcinoma but FC accounts for more deaths 
than PC [9]. Follicular carcinoma occurs in older age, 
has hematogenous spread , is more aggressive unlike 
papillary carcinoma which presents in younger age, has 
lymphatic spread and is less aggressive than FC 
[10,11]. FC is the second most prevalent of thyroid 
carcinomas with an incidence of 10-20 %. 
Hematogeous metastases are commonly to lung, bone, 
other solid organs. Lymphatic spread is seen in 10 % , 
cases of F.C. Patients with differentiated thyroid  
carcinoma (DTC) have a 10 year survival rate of 80-95 
%. However, 10 year survival rate is 4 % with presence 
of distant metastases [12]. Bone metastases in F.C. 
occurs in 7-28 % of patients involving long bones such 
as femur and flat bones mainly pelvis and sternum 
[13].  
Staging of Follicular carcinoma thyroid is based on age 
of the patient. Older than 45 years of age and younger 
than 45 years of age. Staging for patients younger than 
45 years, it is stage I if carcinoma is confined to only 
the thyroid with no lymph node involvement or 
metastases and stage II for patients with distant 
metastases.  
Adverse prognostic factors in patients with metastases 
to lung &/or bone are multiplies of sites, older patients 
age at time of metastases and absence of radioactive 
iodine uptake by the metastases [14].  
There are few case reports for differentiated thyroid 
carcinoma metastasizing to uncommon sites like brain, 
eye, parapharyngeal , breast, esophagus, liver, 
pancreas, intestine, renal adrenal, ovarian, uterus, 
muscle and skin [15]. Brain metastases are extremely 
rare, occurring more frequently in the cerebral 
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hemispheres, less frequently in the pituitary, cerebellar 
hemisphere, cerebello-pontine angle. Brain metastases 
in most cases are asymptomatic, with few having 
symptoms like headache and numbness of feet. Brain 
metastasis is a negative prognostic factor with a 
tendency for recurrence [15].  F.C. primarily 
metastasizes via the blood whereas P.C. primarily 
metastasizes via the lymphatic system [16] which 
explains the lower incidence of cervical 
lymphadenopathy in F.C. than in P.C. In the present 
case, the cervical lymph nodes were not infiltrated. 
FC has greater preponderance than PC for cutaneous 
metastases. Common sites of cutaneous metastases are 
scalp, face, chest wall, abdomen, back, thigh , pelvic 
region as tumor emboli are trapped from circulation for 
formation of metastatic foci [17].   
 
Conclusion 
 
FNAC is a cost effective and minimally invasive 
method of detecting malignancy in thyroid nodules. FC 
cannot be confirmed on FNAC but in the present case 
malignant behavior of FC was confirmed by 
cytomorphology of metastatic lesion. FC often presents 
at a higher tumor stages. As in present case, presenting 
symptom was swelling in skull and chest wall. FNAC 
from chest wall lesion showed metastases of Follicular 
carcinoma of thyroid though FNAC from intra thyroid 
lesion did not yield cellularity as it was calcified. The 
cytological diagnosis was confirmed histologically and 
by Immunohistochemistry by taking core needle biopsy 
of chest wall lesion.  
 
The present case was diagnostically challenging as 
there were no symptoms of the primary tumor. 
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